Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics (Keta4SI)
Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics: a Pilot Randomized Controlled Trial
Sponsor: University of British Columbia
Terminated
There were challenges with recruitment in the ED due to ED staffing shortages and we were unable to meet the expected recruitment rate. The decision to stop study recruitment was solely due to operational and logistical limitations.
Other terminated trials from University of British Columbia
Other Suicidal Ideation trials with similar outcome
A PHASE1/PHASE2 clinical study on Suicidal Ideation, this trial is terminated or withdrawn. The trial is conducted by University of British Columbia and has accumulated 7 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Jan 2025 — Present [monthly]
Terminated PHASE1/PHASE2
Status: Recruiting → Terminated
-
Sep 2024 — Jan 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Dec 2022 — Jul 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2022 — Dec 2022 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Oct 2021 — Jun 2022 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of British Columbia
For direct contact, visit the study record on ClinicalTrials.gov .